UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): March 17, 2004
--------------
Escalon Medical Corp.
------------------------------------------------------
(Exact name of registrant as specified in its charter)
Pennsylvania 0-20127 33-0272839
------------ ------------------------ ------------------
(State or other (Commission file number) (IRS employer
jurisdiction of identification no.)
incorporation)
575 East Swedesford Road, Suite 100
Wayne, Pennsylvania 19087
---------------------------------------- --------
(Address of principal executive offices) (Zip code)
Registrant's telephone number, including area code: (215) 688-6830
--------------
N/A
-------------------------------------------------------------
(Former name or former address, if changed since last report)
Item 5. Other Events and Regulation FD Disclosure.
On March 17, 2004, the Company issued a press release
announcing its completion of a private placement of 800,000 shares of Common
Stock and warrants to purchase 120,000 shares of Common Stock to certain
accredited and institutional investors. A copy of the press release is attached
as an exhibit to this Form 8-K current report.
Item 7. Financial Statements and Exhibits.
(c) Exhibits.
The following exhibit is filed herewith:
Exhibit No. Description
----------- -----------
99.1 Press release issued by Escalon Medical
Corp. (the "Company") dated March 17, 2004
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
ESCALON MEDICAL CORP.
Date: March 17, 2004 By: /s/ Richard J. DePiano
-----------------------
Richard J. DePiano
Chairman and
Chief Executive Officer
3
EXHIBIT INDEX
Exhibit
Number Description
------ -----------
99.1 Press release dated March 17, 2004 issued by the Company.